Viruses Treatment Articles

Hope Remains For Alzheimer's Sufferers

November 22, 2017

The National Institute of Clinical Excellence (NICE), who last week rejected appeals to allow patients with mild Alzheimer's to receive the life-changing medication donepezil (Aricept®), will hopefully re-appraise their decision in three-years time, according to neurologist Professor Robert Kerwin in an article published in the November issue of the medical journal Future Neurology. Kerwin evaluated recent research published in the Lancet that may not have been taken into account by the NIC...

IBHS Cautions Businesses To Prepare For Flu Pandemic; Provides Free Self-Assessment Tool To Rate Readiness

November 21, 2017

The Institute for Business & Home Safety (IBHS) is cautioning businesses and nonprofit organizations to examine their ability to operate in the event of a flu pandemic. With the federal government declaring Swine Flu a public-health emergency, IBHS says it would be wise to prepare now for the possibility of closures or other impacts a pandemic could have on operations. "Evaluating specific risks and planning well beforehand for a variety of potential emergencies that could disrupt day-to-day bus...

School Of Medicine Receives $30 Million Grant To Coordinate A Consortium Of National Stem Cell Experts

November 20, 2017

A University of Maryland School of Medicine researcher will lead the coordinating center for a consortium of our nation's most prominent scientists in the field of stem cell research. Michael L. Terrin, M.D.,C.M.,M.P.H., professor of Epidemiology and Preventive Medicine, was chosen by the National Heart, Lung and Blood Institute (NHLBI) to coordinate the research of this consortium of national experts, which will be called the NHLBI Progenitor Cell Biology Consortium. The coordinating center wil...

AFM Analyses For Africa Malaria Day

November 19, 2017

Africa Malaria Day, April 25th, commemorates the 1.2 million people lost each year to a preventable and curable disease. Malaria is the biggest killer of African kids. Half a billion people suffer from it annually, reducing economic productivity around the world. Political will and public funding to target this disease are increasing, but there is still room to improve efforts to measure, assess, and inform evidence-based policies and programs. Africa Fighting Malaria (AFM) provides below an...

Shire Announces Launch Of FOSRENOL(R) In Japan - Management Of Hyperphosphataemia In End-Stage Renal Disease Patients

November 18, 2017

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announces the Japanese launch of FOSRENOL(R) (lanthanum carbonate), which is now available to prescribers and patients in Japan through Shire's strategic alliance partner Bayer Yakuhin Ltd. FOSRENOL is the first commercially available non-calcium, non-resin phosphate binder in Japan and is used in the control of hyperphosphataemia in chronic renal failure patients on dialysis. ...